{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cannabis", "Drug and narcotic control", "Drug legislation", "Medical marijuana"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [{"AbstractText": ["El consumo de la mariguana conlleva un importante impacto cultural en M\u00e9xico. Su efecto psicol\u00f3gicamente estimulante es ampliamente reconocido, sus componentes bioqu\u00edmicos y moleculares interact\u00faan con los receptores CB1 y CB2 (sistema endocannabinoide) en diversas estructuras del sistema nervioso central (SNC) y de las c\u00e9lulas inmunes. El elemento psicoactivo \u0394-9-Tetrahidrocannabinol (THC) puede ser reproducido sint\u00e9ticamente.Revisiones sistem\u00e1ticas muestran evidencia en efectividad del consumo de mariguana terap\u00e9utica solo para ciertos s\u00edntomas de esclerosis m\u00faltiple (espasticidad, espasmos y dolor), a pesar de los intentos para su uso extenso, incluyendo epilepsias infantiles refractarias. La evidencia se\u00f1ala importantes efectos adversos de la mariguana fumada sobre las estructuras, el funcionamiento y la conectividad cerebral. La exposici\u00f3n al cannabis durante el embarazo afecta el desarrollo cerebral del feto, pudiendo generar problemas conductuales tard\u00edos en los hijos. Pruebas sensitivas neuropsicol\u00f3gicas y avanzadas t\u00e9cnicas imagenol\u00f3gicas demuestran afectaci\u00f3n en el proceso de aprendizaje en adolescentes consumidores. Asimismo, la mariguana aumenta el deterioro cognitivo en pacientes con esclerosis m\u00faltiple. Las consecuencias sociales y \u00e9ticas al liberar legalmente mariguana para uso l\u00fadico pueden ser trascendentalmente delet\u00e9reas. El cannabinol medicinal sin efecto psicoactivo o adictivo requiere de estudios controlados de eficacia y seguridad comprobadas antes de su aprobaci\u00f3n regulatoria."]}], "PMID": "27428345", "DateCompleted": {"Year": "2017", "Month": "05", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [], "ELocationID": [], "Language": ["spa"], "Journal": {"ISSN": "2448-5667", "JournalIssue": {"Volume": "54", "Issue": "5", "PubDate": {"Year": "2016", "Season": "Sep-Oct"}}, "Title": "Revista medica del Instituto Mexicano del Seguro Social", "ISOAbbreviation": "Rev Med Inst Mex Seguro Soc"}, "ArticleTitle": "[Cannabis: Effects in the Central Nervous System. Therapeutic, societal and legal consequences].", "Pagination": {"StartPage": "626", "EndPage": "634", "MedlinePgn": "626-34"}, "Abstract": {"AbstractText": ["The consumption of marijuana extracted from Cannabis sativa and indica plants involves an important cultural impact in Mexico. Their psychological stimulatory effect is widely recognized; their biochemical and molecular components interact with CB1 and CB2 (endocannabinoid system) receptors in various central nervous system structures (CNS) and immune cells. The psychoactive element \u0394-9-tetrahydrocannabinol (THC) can be reproduced synthetically. Systematic reviews show evidence of therapeutic effectiveness of therapeutic marijuana only for certain symptoms of multiple sclerosis (spasticity, spasms and pain), despite attempts for its widespread use, including refractory childhood epilepsy. Evidence indicates significant adverse effects of smoked marijuana on the structure, functioning and brain connectivity. Cannabis exposure during pregnancy affects fetal brain development, potentially leading to later behavioral problems in children. Neuropsychological tests and advanced imaging techniques show involvement in the learning process in adolescents with substance use. Also, marijuana increases the cognitive impairment in patients with multiple sclerosis. Social and ethical consequences to legally free marijuana for recreational use may be deleterious transcendentally. The medicinal or psychoactive cannabinol no addictive effect requires controlled proven efficacy and safety before regulatory approval studies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Neurolog\u00eda, Baylor College of Medicine, Houston, Texas, EUA. vrivera@bcm.edu."}], "LastName": "Rivera-Olmos", "ForeName": "V\u00edctor Manuel", "Initials": "VM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Parra-Bernal", "ForeName": "Marisela C", "Initials": "MC"}], "PublicationTypeList": ["Journal Article", "Review"], "VernacularTitle": "Cannabis: efectos en el sistema nervioso central. Consecuencias terap\u00e9uticas, sociales y legales."}, "MedlineJournalInfo": {"Country": "Mexico", "MedlineTA": "Rev Med Inst Mex Seguro Soc", "NlmUniqueID": "101243727", "ISSNLinking": "0443-5117"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Medical Marijuana"}], "MeshHeadingList": [{"QualifierName": ["adverse effects"], "DescriptorName": "Cannabis"}, {"QualifierName": ["drug effects", "physiology"], "DescriptorName": "Central Nervous System"}, {"QualifierName": [], "DescriptorName": "Cultural Characteristics"}, {"QualifierName": [], "DescriptorName": "Drug and Narcotic Control"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects", "legislation & jurisprudence"], "DescriptorName": "Marijuana Smoking"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Medical Marijuana"}, {"QualifierName": [], "DescriptorName": "Mexico"}, {"QualifierName": [], "DescriptorName": "Social Conditions"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "7", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "7", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "4", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27428345"]}}], "PubmedBookArticle": []}